German Christopher Paul's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Mar 6, 2026
- Accession no.
- 0001104659-26-024750
- Filed
- Mar 6, 2026
- Trade date
- Mar 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $502.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| German Christopher PaulCIK 0001260835 | Officer (Corporate Controller & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | MOption exerciseAcquired | +1,500 | $17.97 | +$26,955 | 5,753 | Direct | |
| Mar 4, 2026 | Common Stock | SSaleDisposed | −5,614 | $89.56 | −$502,789.84 | 160 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 3,731 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.